Trial Profile
The Correlation Between the Moment of Bevacizumab theRapy initiatiOn and the Efficacy in patieNt With cOlorectal Cancer Treated With AvaStin Based First Line Regimens (CRONOS 1)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms CRONOS 1
- Sponsors Roche
- 14 Sep 2016 Status changed from active, no longer recruiting to discontinued as contract terminated with Site Management Organization.
- 05 Feb 2015 Planned End Date changed from 1 Jun 2015 to 1 Apr 2016, as reported by ClinicalTrials.gov.
- 05 Feb 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Apr 2016, as reported by ClinicalTrials.gov.